Skip to main content

Table 3 Other outcomes including adverse events

From: Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial

Variable

Group A

Group B

P value

Ecchymoses morbidity

7

38

0.001

Area of ecchymoses(%)b

1.6 ± 0.7

3.0 ± 1.3

0.001

 Symptomatic DVT

0

0

NA

 Asymptomatic DVT

5

3

0.50

 Superficial infection

0

0

1.00

 Deep infection

0

0

NA

 Hematoma

0

0

NA

 Wound secretion

2

1

0.58

30-day mortality

0

0

NA

90-day readmission

0

0

NA

Satisfaction level

 Extremely satisfied

21

18

0.88

 Very satisfied

19

17

 

 Somewhat satisfied

12

11

 

 Neither satisfied nor dissatisfied

7

10

 

 Somewhat dissatisfied

1

2

 

 Very dissatisfied

0

0

Â